TD Cowen Initiates Coverage On Faeth Therapeutics with Buy Rating

Benzinga · 1d ago
TD Cowen analyst Tara Bancroft initiates coverage on Faeth Therapeutics (NASDAQ:FTH) with a Buy rating.